Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study)
Helena Kattelus, Y. Antero Kesäniemi, Heikki V. Huikuri, et al.
PLoS ONE (2018) Vol. 13, Iss. 10, pp. e0205454-e0205454
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis
Orly Leiva, Duaa AbdelHameid, Jean M. Connors, et al.
JACC CardioOncology (2021) Vol. 3, Iss. 5, pp. 619-634
Open Access | Times Cited: 94
Atrial fibrillation and cancer – An unexplored field in cardiovascular oncology
Gordon Chu, Henri H. Versteeg, Arie J. Verschoor, et al.
Blood Reviews (2019) Vol. 35, pp. 59-67
Closed Access | Times Cited: 84
The Association of Malignancy With Stroke and Bleeding in Atrial Fibrillation
Malak El-Rayes, Mohamed A. Adam, Jiming Fang, et al.
JACC CardioOncology (2025)
Open Access | Times Cited: 1
Atrial fibrillation and cancer: prevalence and relative risk from a nationwide study
Cihan Ay, Ella Grilz, Stephan Nopp, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 1, pp. 100026-100026
Open Access | Times Cited: 20
SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes
Ammar Bhatti, Rushin Patel, Sourbha S. Dani, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 6, pp. 863-875
Open Access | Times Cited: 7
Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect
Juan Tamargo, Julián Pérez‐Villacastín, Ricardo Caballero, et al.
Pharmacological Research (2024) Vol. 200, pp. 107077-107077
Open Access | Times Cited: 6
Cancer and stroke: What do we know and where do we go?
Ronda Lun, Deborah Siegal, Tim Ramsay, et al.
Thrombosis Research (2022) Vol. 219, pp. 133-140
Closed Access | Times Cited: 22
Atrial Fibrillation in Cancer Patients: Epidemiology, Identification and Management
Chengqi Yu, Leilei Jiang, Liuhua Long, et al.
Seminars in Cancer Biology (2025) Vol. 111, pp. 39-47
Closed Access
Atrial fibrillation and cancer; understanding the mysterious relationship through a systematic review
Noman Lateef, Vikas Kapoor, Muhammad Junaid Ahsan, et al.
Journal of Community Hospital Internal Medicine Perspectives (2020) Vol. 10, Iss. 2, pp. 127-132
Open Access | Times Cited: 28
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016
Shirin Ardeshir‐Rouhani‐Fard, Huijun An, RK Goyal, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2022) Vol. 42, Iss. 5, pp. 375-386
Open Access | Times Cited: 17
Safety of catheter ablation for atrial fibrillation in patients with cancer: a nationwide cohort study
Sahith Reddy Thotamgari, Aakash Sheth, Harsh Patel, et al.
Postgraduate Medicine (2023) Vol. 135, Iss. 6, pp. 562-568
Closed Access | Times Cited: 9
Interconnected Clinical and Social Risk Factors in Breast Cancer and Heart Failure
Arjun Sinha, Avni Bavishi, Elizabeth A. Hibler, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Atrial fibrillation in cancer survivors – a systematic review and meta-analysis
Yueyang Bao, John Lee, Udit Thakur, et al.
Cardio-Oncology (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Dyspnoea in Oncological Patients: A Brain Teaser
Kalliopi Keramida, Athanasios Kostoulas
European Cardiology Review (2023) Vol. 18
Open Access | Times Cited: 6
Safety and Efficacy of Cryoballoon Based Pulmonary Vein Isolation in Patients with Atrial Fibrillation and a History of Cancer
Charlotte Eitel, Vanessa Sciacca, Nina K. Bartels, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3669-3669
Open Access | Times Cited: 15
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils
Lauren A. Baldassarre, Eric H. Yang, Richard K. Cheng, et al.
JNCI Journal of the National Cancer Institute (2020) Vol. 113, Iss. 5, pp. 513-522
Open Access | Times Cited: 15
Carotid intima‐media thickness in young survivors of childhood cancer
Maryna Krawczuk‐Rybak, Monika Tomczuk‐Ostapczuk, Anna Panasiuk, et al.
Journal of Medical Imaging and Radiation Oncology (2016) Vol. 61, Iss. 1, pp. 85-92
Closed Access | Times Cited: 13
Antithrombotic strategy in cancer patients comorbid with acute coronary syndrome and atrial fibrillation
Tianbo Wang, Xiaohan Liu, Yuxin Zhu, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Identification of atrial fibrillation-related genes through transcriptome data analysis and Mendelian randomization
Yujun Zhang, Qiufang Lian, Yanwu Nie, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Direct oral anticoagulants in the prevention of stroke in breast cancer patients with atrial fibrillation during adjuvant endocrine therapy: A cohort study
Renata Pacholczak‐Madej, Stanisława Bazan‐Socha, Lech Zaręba, et al.
International Journal of Cardiology (2020) Vol. 324, pp. 78-83
Closed Access | Times Cited: 11
Intracranial Hemorrhage in Patients with Anticoagulant Therapy Undergoing Stereotactic Radiosurgery for Brain Metastases: A Bi-Institutional Analysis
Felix Ehret, David Kaul, Lucas Mose, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 465-465
Open Access | Times Cited: 6
Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?
Sabina Mędrek, Sebastian Szmit
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Preventive Cardio-Oncology: Cardiovascular Disease Prevention in Cancer Patients and Survivors
Iacopo Fabiani, Mary Branch, Daniela Cardinale, et al.
Current Treatment Options in Cardiovascular Medicine (2021) Vol. 23, Iss. 1
Closed Access | Times Cited: 8
Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies
Anastasia Perpinia, Nikolaos P.E. Kadoglou, Maria Vardaka, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1007-1007
Open Access | Times Cited: 5
Impact of timing of atrial fibrillation, CHA2DS2-VASc score and cancer therapeutics on mortality in oncology patients
Muzna Hussain, Rabel Misbah, Eoin Donnellan, et al.
Open Heart (2020) Vol. 7, Iss. 2, pp. e001412-e001412
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top